Clinical trials recruiting in Forest City, North Carolina
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 7Not applicable 1
Conditions recruiting in Forest City, North Carolina
Recruiting trials in Forest City, North Carolina
- Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- E-Mindfulness Approaches for Living After Breast Cancer
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Common questions
How many clinical trials are recruiting in Forest City, North Carolina?
8 recruiting trials have at least one study site in Forest City, North Carolina.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.